Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Ophthalmic Drug

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1178475

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1178475

Global Pingueculum Drugs Market - Industry Trends and Forecast to 2029

PUBLISHED:
PAGES: 383 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 4800
PDF (Enterprise License) - Printable/Downloadable
USD 7000

Add to Cart

Description

Table of Contents

List of Tables

The global pingueculum drugs market is projected to register a substantial CAGR of 7.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation:

Global Pingueculum Drugs Market, By Treatment (Artificial Tears /Topical Lubricants, Steroid Eye Drops, Non-steroidal Anti Inflammatory Drops, and Others), Formulation Type (Eye Drops, Eye Ointments, and Others), Mode of Purchase (Prescription, Over the Counter), Drug Type (Branded, Generics), Population Type (Geriatric, Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Country (U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of the Middle East and Africa) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the global pingueculum drugs market are:

Rise in the prevalence of pingueculum disease around the globe

Rise in the UV exposure to the individuals due to ozone defect casing pingueculum more frequently

Market Players:

Some of the major players operating in the global pingueculum drugs market are:

AbbVie Inc.

Amneal Pharmaceuticals LLC.

Spectra Vision Care

SAGER PHARMA

Maya Biotech Private Limited

Novartis AG

Akorn Operating Company LLC

Thea Laboratories

OASIS Medical, Inc.

Similasan Corporation

Bausch & Lomb Incorporated

Prestige Consumer Healthcare, Inc.

Alcon Inc.

Wellona Pharma

Johnson & Johnson Vision Care, Inc.

EYERIS VISIONCARE Pvt. Ltd.

Sylentis

Zydus Group

Bayer AG

Santen Pharmaceutical Co., Ltd.

Show more

TABLE OF CONTENTS

1 INTRODUCTION 44

  • 1.1 OBJECTIVES OF THE STUDY 44
  • 1.2 MARKET DEFINITION 44
  • 1.3 OVERVIEW OF THE GLOBAL PINGUECULUM DRUGS MARKET 44
  • 1.4 CURRENCY AND PRICING 46
  • 1.5 LIMITATIONS 46
  • 1.6 MARKETS COVERED 47

2 GLOBAL PINGUECULUM DRUGS MARKET: SEGMENTATION 49

  • 2.1 MARKETS COVERED 49
  • 2.2 GEOGRAPHICAL SCOPE 50
  • 2.3 YEARS CONSIDERED FOR THE STUDY 51
  • 2.4 CURRENCY AND PRICING 51
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 52
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 55
  • 2.7 MULTIVARIATE MODELLING 56
  • 2.8 TREATMENT LIFELINE CURVE 56
  • 2.9 DBMR MARKET POSITION GRID 57
  • 2.10 VENDOR SHARE ANALYSIS 59
  • 2.11 MARKET END-USER COVERAGE GRID 60
  • 2.12 SECONDARY SOURCES 61
  • 2.13 ASSUMPTIONS 61

3 EXECUTIVE SUMMARY 62

4 PREMIUM INSIGHTS 66

  • 4.1 EPIDERMIOLOGY 68
  • 4.2 PESTEL ANALYSIS 69
  • 4.3 PORTER'S FIVE FORCES 70
  • 4.4 PIPELINE ANALYSIS FOR THE GLOBAL PINGUECULUM DRUGS MARKET 71
  • 4.5 INDUSTRIAL INSIGHTS: 72
  • 4.6 CONCLUSION: 72

5 GLOBAL PINGUECULUM DRUGS MARKET: REGULATIONS 73

6 MARKET OVERVIEW 76

  • 6.1 DRIVERS 78
    • 6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS 78
    • 6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT 78
    • 6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES 79
    • 6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT 80
  • 6.2 RESTRAINTS 80
    • 6.2.1 STRINGENT RULES & REGULATIONS 80
    • 6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT 81
  • 6.3 OPPORTUNITIES 82
    • 6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES 82
    • 6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES 82
    • 6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME 83
  • 6.4 CHALLENGES 84
    • 6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS 84
    • 6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS 85

7 GLOBAL PINGUECULUM DRUGS MARKET, BY TREATMENT 86

  • 7.1 OVERVIEW 87
  • 7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS 90
    • 7.2.1 DEMULCENT 90
    • 7.2.2 EMOLLIENTS 90
  • 7.3 STEROID EYE DROPS 91
    • 7.3.1 KETONE STEROIDS 92
      • 7.3.1.1 PREDNISOLONE 92
      • 7.3.1.2 DEXAMETHASONE 92
      • 7.3.1.3 FLUROMETHOLONE 92
      • 7.3.1.4 MEDRYSONE 92
      • 7.3.1.5 RIMEXOLONE 92
      • 7.3.1.6 OTHERS 92
    • 7.3.2 ESTER STEROID (LOTERPREDNOL) 93
  • 7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS 93
  • 7.5 OTHERS 93

8 GLOBAL PINGUECULUM DRUGS MARKET, BY FORMULATION 94

  • 8.1 OVERVIEW 95
  • 8.2 EYE DROPS 98
    • 8.2.1 EYE DROPS WITH PRESERVATIVES 98
    • 8.2.2 PRESERVATIVE-FREE EYE DROPS 98
  • 8.3 EYE OINTMENTS 99
    • 8.3.1 WITH PRESERVATIVES 99
    • 8.3.2 PRESERVATIVE-FREE 99
    • 8.3.3 OTHERS 99
  • 8.4 OTHERS 100

9 GLOBAL PINGUECULUM DRUGS MARKET, MODE OF PURCHASE 101

  • 9.1 OVERVIEW 102
  • 9.2 PRESCRIPTION 105
  • 9.3 OVER THE COUNTER (OTC) 105

10 GLOBAL PINGUECULUM DRUGS MARKET, BY DRUGS TYPE 106

  • 10.1 OVERVIEW 107
  • 10.2 BRANDED 110
  • 10.3 GENERICS 110

11 GLOBAL PINGUECULUM DRUGS MARKET, BY POPULATION TYPE 111

  • 11.1 OVERVIEW 112
  • 11.2 GERIATRIC 115
    • 11.2.1 MALE 115
    • 11.2.2 FEMALE 115
  • 11.3 ADULTS 116
    • 11.3.1 MALE 116
    • 11.3.2 FEMALE 116

12 GLOBAL PINGUECULUM DRUGS MARKET, BY END USER 117

  • 12.1 OVERVIEW 118
  • 12.2 HOSPITALS 121
  • 12.3 SPECIALTY CLINICS 121
  • 12.4 HOME HEALTHCARE 122
  • 12.5 OTHERS 122

13 GLOBAL PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL 123

  • 13.1 OVERVIEW 124
  • 13.2 RETAIL PHARMACIES 127
  • 13.3 HOSPITAL PHARMACIES 127
  • 13.4 ONLINE PHARMACIES 128
  • 13.5 OTHERS 128

14 GLOBAL PINGUECULUM DRUGS MARKET, BY REGION 129

  • 14.1 OVERVIEW 130
  • 14.2 ASIA-PACIFIC 136
    • 14.2.1 CHINA 146
    • 14.2.2 INDIA 150
    • 14.2.3 JAPAN 154
    • 14.2.4 INDONESIA 158
    • 14.2.5 SOUTH KOREA 162
    • 14.2.6 AUSTRALIA 166
    • 14.2.7 THAILAND 170
    • 14.2.8 VIETNAM 174
    • 14.2.9 PHILIPPINES 178
    • 14.2.10 MALAYSIA 182
    • 14.2.11 SINGAPORE 186
    • 14.2.12 REST OF ASIA- PACIFIC 190
  • 14.3 EUROPE 191
    • 14.3.1 SPAIN 200
    • 14.3.2 RUSSIA 204
    • 14.3.3 TURKEY 208
    • 14.3.4 GERMANY 212
    • 14.3.5 ITALY 216
    • 14.3.6 U.K. 220
    • 14.3.7 FRANCE 224
    • 14.3.8 HUNGARY 228
    • 14.3.9 AUSTRIA 232
    • 14.3.10 SWITZERLAND 236
    • 14.3.11 NETHERLANDS 240
    • 14.3.12 POLAND 244
    • 14.3.13 IRELAND 248
    • 14.3.14 NORWAY 252
    • 14.3.15 LITHUANIA 256
    • 14.3.16 REST OF EUROPE 260
  • 14.4 NORTH AMERICA 261
    • 14.4.1 U.S. 270
    • 14.4.2 MEXICO 274
    • 14.4.3 CANADA 278
  • 14.5 SOUTH AMERICA 282
    • 14.5.1 BRAZIL 291
    • 14.5.2 ARGENTINA 295
    • 14.5.3 PERU 299
    • 14.5.4 REST OF SOUTH AMERICA 303
  • 14.6 MIDDLE EAST AND AFRICA 304
    • 14.6.1 SOUTH AFRICA 313
    • 14.6.2 EGYPT 317
    • 14.6.3 ISRAEL 321
    • 14.6.4 U.A.E 325
    • 14.6.5 SAUDI ARABIA 329
    • 14.6.6 KUWAIT 333
    • 14.6.7 REST OF MIDDLE EAST AND AFRICA 337

15 GLOBAL PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE 338

  • 15.1 COMPANY SHARE ANALYSIS: GLOBAL 338
  • 15.2 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 339
  • 15.3 COMPANY SHARE ANALYSIS: NORTH AMERICA 340
  • 15.4 COMPANY SHARE ANALYSIS: EUROPE 341

16 SWOT ANALYSIS 342

17 COMPANY PROFILE 343

  • 17.1 ALCON INC. 343
    • 17.1.1 COMPANY SNAPSHOT 343
    • 17.1.2 REVENUE ANALYSIS 343
    • 17.1.3 COMPANY SHARE ANALYSIS 344
    • 17.1.4 PRODUCT PORTFOLIO 344
    • 17.1.5 RECENT DEVELOPMENT 344
  • 17.2 ABBVIE INC. 345
    • 17.2.1 COMPANY SNAPSHOT 345
    • 17.2.2 REVENUE ANALYSIS 345
    • 17.2.3 COMPANY SHARE ANALYSIS 346
    • 17.2.4 PRODUCT PORTFOLIO 346
    • 17.2.5 RECENT DEVELOPMENT 347
  • 17.3 BAUSCH & LOMB INCORPORATED 348
    • 17.3.1 COMPANY SNAPSHOT 348
    • 17.3.2 REVENUE ANALYSIS 348
    • 17.3.3 COMPANY SHARE ANALYSIS 349
    • 17.3.4 PRODUCT PORTFOLIO 349
    • 17.3.5 RECENT DEVELOPMENT 350
  • 17.4 BAYER AG 351
    • 17.4.1 COMPANY SNAPSHOT 351
    • 17.4.2 REVENUE ANALYSIS 351
    • 17.4.3 COMPANY SHARE ANALYSIS 352
    • 17.4.4 PRODUCT PORTFOLIO 352
    • 17.4.5 RECENT DEVELOPMENTS 352
  • 17.5 JOHNSON & JOHNSON VISION CARE, INC. 353
    • 17.5.1 COMPANY SNAPSHOT 353
    • 17.5.2 REVENUE ANALYSIS 353
    • 17.5.3 COMPANY SHARE ANALYSIS 354
    • 17.5.4 PRODUCT PORTFOLIO 354
    • 17.5.5 RECENT DEVELOPMENT 354
  • 17.6 AKORN OPERATING COMPANY LLC 355
    • 17.6.1 COMPANY SNAPSHOT 355
    • 17.6.2 . PRODUCT PORTFOLIO 355
    • 17.6.3 RECENT DEVELOPMENT 355
  • 17.7 AMNEAL PHARMACEUTICALS LLC. 356
    • 17.7.1 COMPANY SNAPSHOT 356
    • 17.7.2 REVENUE ANALYSIS 356
    • 17.7.3 PRODUCT PORTFOLIO 357
    • 17.7.4 RECENT DEVELOPMENTS 357
  • 17.8 EYERIS VISIONCARE PVT. LTD. 358
    • 17.8.1 COMPANY SNAPSHOT 358
    • 17.8.2 PRODUCT PORTFOLIO 358
    • 17.8.3 RECENT DEVELOPMENTS 359
  • 17.9 LABORATOIRES THEA 360
    • 17.9.1 COMPANY SNAPSHOT 360
    • 17.9.2 PRODUCT PORTFOLIO 360
    • 17.9.3 RECENT DEVELOPMENT 361
  • 17.10 MAYA BIOTECH PRIVATE LIMITED 362
    • 17.10.1 COMPANY SNAPSHOT 362
    • 17.10.2 PRODUCT PORTFOLIO 362
    • 17.10.3 RECENT DEVELOPMENTS 363
  • 17.11 NOVARTIS AG 364
    • 17.11.1 COMPANY SNAPSHOT 364
    • 17.11.2 REVENUE ANALYSIS 364
    • 17.11.3 PRODUCT PORTFOLIO 365
    • 17.11.4 RECENT DEVELOPMENT 365
  • 17.12 OASIS MEDICAL, INC. 366
    • 17.12.1 COMPANY SNAPSHOT 366
    • 17.12.2 PRODUCT PORTFOLIO 366
    • 17.12.3 RECENT DEVELOPMENT 366
  • 17.13 PRESTIGE CONSUMER HEALTHCARE, INC. 367
    • 17.13.1 COMPANY SNAPSHOT 367
    • 17.13.2 PRODUCT PORTFOLIO 368
    • 17.13.3 RECENT DEVELOPMENT 368
  • 17.14 SAGER PHARMA 369
    • 17.14.1 COMPANY SNAPSHOT 369
    • 17.14.2 PRODUCT PORTFOLIO 369
    • 17.14.3 RECENT DEVELOPMENTS 369
  • 17.15 SANTEN PHARMACEUTICAL CO., LTD. 370
    • 17.15.1 COMPANY SNAPSHOT 370
    • 17.15.2 REVENUE ANALYSIS 370
    • 17.15.3 PRODUCT PORTFOLIO 371
    • 17.15.4 RECENT DEVELOPMENTS 371
  • 17.16 SIMILASAN CORPORATION 372
    • 17.16.1 COMPANY SNAPSHOT 372
    • 17.16.2 PRODUCT PORTFOLIO 372
    • 17.16.3 RECENT DEVELOPMENTS 372
  • 17.17 SPECTRA VISION CARE 373
    • 17.17.1 COMPANY SNAPSHOT 373
    • 17.17.2 PRODUCT PORTFOLIO 373
    • 17.17.3 RECENT DEVELOPMENTS 374
  • 17.18 SYLENTIS 375
    • 17.18.1 COMPANY SNAPSHOT 375
    • 17.18.2 PRODUCT PORTFOLIO 375
    • 17.18.3 RECENT DEVELOPMENTS 375
  • 17.19 WELLONA PHARMA 376
    • 17.19.1 COMPANY SNAPSHOT 376
    • 17.19.2 PRODUCT PORTFOLIO 376
    • 17.19.3 RECENT DEVELOPMENTS 376
  • 17.20 ZYDUS GROUP 377
    • 17.20.1 COMPANY SNAPSHOT 377
    • 17.20.2 REVENUE ANALYSIS 377
    • 17.20.3 PRODUCT PORTFOLIO 378
    • 17.20.4 RECENT DEVELOPMENTS 378

18 QUESTIONNAIRE 379

19 RELATED REPORTS 383

Show more

LIST OF TABLES

  • TABLE 1 GLOBAL PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 89
  • TABLE 2 GLOBAL ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 90
  • TABLE 3 GLOBAL ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 90
  • TABLE 4 GLOBAL STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 91
  • TABLE 5 GLOBAL STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 91
  • TABLE 6 GLOBAL KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 92
  • TABLE 7 GLOBAL NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 93
  • TABLE 8 GLOBAL OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 93
  • TABLE 9 GLOBAL PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 97
  • TABLE 10 GLOBAL EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 98
  • TABLE 11 GLOBAL EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 98
  • TABLE 12 GLOBAL EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 99
  • TABLE 13 GLOBAL EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 99
  • TABLE 14 GLOBAL OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 100
  • TABLE 15 GLOBAL PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 104
  • TABLE 16 GLOBAL PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 105
  • TABLE 17 GLOBAL OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 105
  • TABLE 18 GLOBAL PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 109
  • TABLE 19 GLOBAL BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 110
  • TABLE 20 GLOBAL GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 110
  • TABLE 21 GLOBAL PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 114
  • TABLE 22 GLOBAL GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 115
  • TABLE 23 GLOBAL GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 115
  • TABLE 24 GLOBAL ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 116
  • TABLE 25 GLOBAL ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 116
  • TABLE 26 GLOBAL PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 120
  • TABLE 27 GLOBAL HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 121
  • TABLE 28 GLOBAL SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 121
  • TABLE 29 GLOBAL HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 122
  • TABLE 30 GLOBAL OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 122
  • TABLE 31 GLOBAL PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 126
  • TABLE 32 GLOBAL RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 127
  • TABLE 33 GLOBAL HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 127
  • TABLE 34 GLOBAL ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 128
  • TABLE 35 GLOBAL OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 128
  • TABLE 36 GLOBAL PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 135
  • TABLE 37 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 141
  • TABLE 38 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 141
  • TABLE 39 ASIA-PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 141
  • TABLE 40 ASIA-PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 142
  • TABLE 41 ASIA-PACIFIC KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 142
  • TABLE 42 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 142
  • TABLE 43 ASIA-PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 143
  • TABLE 44 ASIA-PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 143
  • TABLE 45 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 143
  • TABLE 46 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 143
  • TABLE 47 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 48 ASIA-PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 49 ASIA-PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 50 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 144
  • TABLE 51 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 145
  • TABLE 52 CHINA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 146
  • TABLE 53 CHINA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 54 CHINA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 55 CHINA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 147
  • TABLE 56 CHINA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 147
  • TABLE 57 CHINA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 147
  • TABLE 58 CHINA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 148
  • TABLE 59 CHINA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 148
  • TABLE 60 CHINA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 61 CHINA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 62 CHINA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 149
  • TABLE 63 CHINA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 149
  • TABLE 64 CHINA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 149
  • TABLE 65 CHINA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 149
  • TABLE 66 INDIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 150
  • TABLE 67 INDIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 150
  • TABLE 68 INDIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 150
  • TABLE 69 INDIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 151
  • TABLE 70 INDIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 151
  • TABLE 71 INDIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 151
  • TABLE 72 INDIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 152
  • TABLE 73 INDIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 152
  • TABLE 74 INDIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 152
  • TABLE 75 INDIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 152
  • TABLE 76 INDIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 153
  • TABLE 77 INDIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 153
  • TABLE 78 INDIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 153
  • TABLE 79 INDIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 153
  • TABLE 80 JAPAN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 154
  • TABLE 81 JAPAN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 82 JAPAN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 83 JAPAN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 155
  • TABLE 84 JAPAN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 155
  • TABLE 85 JAPAN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 155
  • TABLE 86 JAPAN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 156
  • TABLE 87 JAPAN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 156
  • TABLE 88 JAPAN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 156
  • TABLE 89 JAPAN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 156
  • TABLE 90 JAPAN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 157
  • TABLE 91 JAPAN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 157
  • TABLE 92 JAPAN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 157
  • TABLE 93 JAPAN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 157
  • TABLE 94 INDONESIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 158
  • TABLE 95 INDONESIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 158
  • TABLE 96 INDONESIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 158
  • TABLE 97 INDONESIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 159
  • TABLE 98 INDONESIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 159
  • TABLE 99 INDONESIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 159
  • TABLE 100 INDONESIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 160
  • TABLE 101 INDONESIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 160
  • TABLE 102 INDONESIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 160
  • TABLE 103 INDONESIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 160
  • TABLE 104 INDONESIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 161
  • TABLE 105 INDONESIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 161
  • TABLE 106 INDONESIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 161
  • TABLE 107 INDONESIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 161
  • TABLE 108 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 162
  • TABLE 109 SOUTH KOREA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 162
  • TABLE 110 SOUTH KOREA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 162
  • TABLE 111 SOUTH KOREA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 163
  • TABLE 112 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 163
  • TABLE 113 SOUTH KOREA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 163
  • TABLE 114 SOUTH KOREA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 164
  • TABLE 115 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 164
  • TABLE 116 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 164
  • TABLE 117 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 164
  • TABLE 118 SOUTH KOREA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 165
  • TABLE 119 SOUTH KOREA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 165
  • TABLE 120 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 165
  • TABLE 121 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 165
  • TABLE 122 AUSTRALIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 166
  • TABLE 123 AUSTRALIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 166
  • TABLE 124 AUSTRALIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 166
  • TABLE 125 AUSTRALIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 167
  • TABLE 126 AUSTRALIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 167
  • TABLE 127 AUSTRALIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 167
  • TABLE 128 AUSTRALIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 168
  • TABLE 129 AUSTRALIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 168
  • TABLE 130 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 168
  • TABLE 131 AUSTRALIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 168
  • TABLE 132 AUSTRALIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 169
  • TABLE 133 AUSTRALIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 169
  • TABLE 134 AUSTRALIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 169
  • TABLE 135 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 169
  • TABLE 136 THAILAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 170
  • TABLE 137 THAILAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 170
  • TABLE 138 THAILAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 170
  • TABLE 139 THAILAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 171
  • TABLE 140 THAILAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 171
  • TABLE 141 THAILAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 171
  • TABLE 142 THAILAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 172
  • TABLE 143 THAILAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 172
  • TABLE 144 THAILAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 172
  • TABLE 145 THAILAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 172
  • TABLE 146 THAILAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 173
  • TABLE 147 THAILAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 173
  • TABLE 148 THAILAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 173
  • TABLE 149 THAILAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 173
  • TABLE 150 VIETNAM PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 174
  • TABLE 151 VIETNAM ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 174
  • TABLE 152 VIETNAM STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 174
  • TABLE 153 VIETNAM KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 175
  • TABLE 154 VIETNAM PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 175
  • TABLE 155 VIETNAM EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 175
  • TABLE 156 VIETNAM EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 176
  • TABLE 157 VIETNAM PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 176
  • TABLE 158 VIETNAM PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 176
  • TABLE 159 VIETNAM PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 176
  • TABLE 160 VIETNAM GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 177
  • TABLE 161 VIETNAM ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 177
  • TABLE 162 VIETNAM PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 177
  • TABLE 163 VIETNAM PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 177
  • TABLE 164 PHILIPPINES PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 178
  • TABLE 165 PHILIPPINES ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 178
  • TABLE 166 PHILIPPINES STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 178
  • TABLE 167 PHILIPPINES KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 179
  • TABLE 168 PHILIPPINES PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 179
  • TABLE 169 PHILIPPINES EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 179
  • TABLE 170 PHILIPPINES EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 180
  • TABLE 171 PHILIPPINES PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 180
  • TABLE 172 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 180
  • TABLE 173 PHILIPPINES PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 180
  • TABLE 174 PHILIPPINES GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 181
  • TABLE 175 PHILIPPINES ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 181
  • TABLE 176 PHILIPPINES PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 181
  • TABLE 177 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 181
  • TABLE 178 MALAYSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 182
  • TABLE 179 MALAYSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 182
  • TABLE 180 MALAYSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 182
  • TABLE 181 MALAYSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 183
  • TABLE 182 MALAYSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 183
  • TABLE 183 MALAYSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 183
  • TABLE 184 MALAYSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 184
  • TABLE 185 MALAYSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 184
  • TABLE 186 MALAYSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 184
  • TABLE 187 MALAYSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 184
  • TABLE 188 MALAYSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 185
  • TABLE 189 MALAYSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 185
  • TABLE 190 MALAYSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 185
  • TABLE 191 MALAYSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 185
  • TABLE 192 SINGAPORE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 186
  • TABLE 193 SINGAPORE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 186
  • TABLE 194 SINGAPORE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 186
  • TABLE 195 SINGAPORE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 187
  • TABLE 196 SINGAPORE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 187
  • TABLE 197 SINGAPORE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 187
  • TABLE 198 SINGAPORE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 188
  • TABLE 199 SINGAPORE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 188
  • TABLE 200 SINGAPORE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 188
  • TABLE 201 SINGAPORE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 188
  • TABLE 202 SINGAPORE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 189
  • TABLE 203 SINGAPORE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 189
  • TABLE 204 SINGAPORE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 189
  • TABLE 205 SINGAPORE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 189
  • TABLE 206 REST OF ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 190
  • TABLE 207 EUROPE PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 196
  • TABLE 208 EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 196
  • TABLE 209 EUROPE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 196
  • TABLE 210 EUROPE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 197
  • TABLE 211 EUROPE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 197
  • TABLE 212 EUROPE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 197
  • TABLE 213 EUROPE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 197
  • TABLE 214 EUROPE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 198
  • TABLE 215 EUROPE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 198
  • TABLE 216 EUROPE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 198
  • TABLE 217 EUROPE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 198
  • TABLE 218 EUROPE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 198
  • TABLE 219 EUROPE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 199
  • TABLE 220 EUROPE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 199
  • TABLE 221 EUROPE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 199
  • TABLE 222 SPAIN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 200
  • TABLE 223 SPAIN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 200
  • TABLE 224 SPAIN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 200
  • TABLE 225 SPAIN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 201
  • TABLE 226 SPAIN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 201
  • TABLE 227 SPAIN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 201
  • TABLE 228 SPAIN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 201
  • TABLE 229 SPAIN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 202
  • TABLE 230 SPAIN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 202
  • TABLE 231 SPAIN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 202
  • TABLE 232 SPAIN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 202
  • TABLE 233 SPAIN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 202
  • TABLE 234 SPAIN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 203
  • TABLE 235 SPAIN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 203
  • TABLE 236 RUSSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 204
  • TABLE 237 RUSSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 204
  • TABLE 238 RUSSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 204
  • TABLE 239 RUSSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 205
  • TABLE 240 RUSSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 205
  • TABLE 241 RUSSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 205
  • TABLE 242 RUSSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 205
  • TABLE 243 RUSSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 206
  • TABLE 244 RUSSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 206
  • TABLE 245 RUSSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 206
  • TABLE 246 RUSSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 206
  • TABLE 247 RUSSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 206
  • TABLE 248 RUSSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 207
  • TABLE 249 RUSSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 207
  • TABLE 250 TURKEY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 208
  • TABLE 251 TURKEY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 208
  • TABLE 252 TURKEY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 208
  • TABLE 253 TURKEY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 209
  • TABLE 254 TURKEY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 209
  • TABLE 255 TURKEY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 209
  • TABLE 256 TURKEY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 209
  • TABLE 257 TURKEY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 210
  • TABLE 258 TURKEY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 210
  • TABLE 259 TURKEY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 210
  • TABLE 260 TURKEY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 210
  • TABLE 261 TURKEY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 210
  • TABLE 262 TURKEY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 211
  • TABLE 263 TURKEY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 211
  • TABLE 264 GERMANY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 212
  • TABLE 265 GERMANY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 212
  • TABLE 266 GERMANY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 212
  • TABLE 267 GERMANY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 213
  • TABLE 268 GERMANY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 213
  • TABLE 269 GERMANY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 213
  • TABLE 270 GERMANY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 213
  • TABLE 271 GERMANY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 214
  • TABLE 272 GERMANY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 214
  • TABLE 273 GERMANY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 214
  • TABLE 274 GERMANY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 214
  • TABLE 275 GERMANY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 214
  • TABLE 276 GERMANY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 215
  • TABLE 277 GERMANY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 215
  • TABLE 278 ITALY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 216
  • TABLE 279 ITALY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 216
  • TABLE 280 ITALY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 216
  • TABLE 281 ITALY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 217
  • TABLE 282 ITALY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 217
  • TABLE 283 ITALY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 217
  • TABLE 284 ITALY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 217

LIST OF FIGURES

  • FIGURE 1 GLOBAL PINGUECULUM DRUGS MARKET: SEGMENTATION 49
  • FIGURE 2 GLOBAL PINGUECULUM DRUGS MARKET: DATA TRIANGULATION 52
  • FIGURE 3 GLOBAL PINGUECULUM DRUGS MARKET: DROC ANALYSIS 53
  • FIGURE 4 GLOBAL PINGUECULUM DRUGS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 54
  • FIGURE 5 GLOBAL PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS 54
  • FIGURE 6 GLOBAL PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS 55
  • FIGURE 7 GLOBAL PINGUECULUM DRUGS MARKET: DBMR POSITION GRID 57
  • FIGURE 8 GLOBAL PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS 59
  • FIGURE 9 GLOBAL PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID 60
  • FIGURE 10 GLOBAL PINGUECULUM DRUGS MARKET: SEGMENTATION 64
  • FIGURE 11 ASIA-PACIFIC IS ANTICIPATED TO DOMINATE THE PINGUECULUM DRUGS MARKET AND GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029 65
  • FIGURE 12 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE GLOBAL PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029 66
  • FIGURE 13 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE GLOBAL PINGUECULUM DRUGS MARKET FROM 2022 & 2029 66
  • FIGURE 14 ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR FOR PINGUECULUM DRUGS MANUFACTURERS IN THE FORECAST PERIOD OF 2022 TO 2029 67
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL PINGUECULUM DRUGS MARKET 77
  • FIGURE 16 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021 87
  • FIGURE 17 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION) 88
  • FIGURE 18 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029) 88
  • FIGURE 19 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE 89
  • FIGURE 20 GLOBAL PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021 95
  • FIGURE 21 GLOBAL PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION) 96
  • FIGURE 22 GLOBAL PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029) 96
  • FIGURE 23 GLOBAL PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE 97
  • FIGURE 24 GLOBAL PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021 102
  • FIGURE 25 GLOBAL PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION) 103
  • FIGURE 26 GLOBAL PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029) 103
  • FIGURE 27 GLOBAL PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE 104
  • FIGURE 28 GLOBAL PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021 107
  • FIGURE 29 GLOBAL PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION) 108
  • FIGURE 30 GLOBAL PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029) 108
  • FIGURE 31 GLOBAL PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE 109
  • FIGURE 32 GLOBAL PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021 112
  • FIGURE 33 GLOBAL PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION) 113
  • FIGURE 34 GLOBAL PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029) 113
  • FIGURE 35 GLOBAL PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE 114
  • FIGURE 36 GLOBAL PINGUECULUM DRUGS MARKET: BY END USER, 2021 118
  • FIGURE 37 GLOBAL PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION) 119
  • FIGURE 38 GLOBAL PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029) 119
  • FIGURE 39 GLOBAL PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE 120
  • FIGURE 40 GLOBAL PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021 124
  • FIGURE 41 GLOBAL PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 125
  • FIGURE 42 GLOBAL PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 125
  • FIGURE 43 GLOBAL PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 126
  • FIGURE 44 GLOBAL PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 131
  • FIGURE 45 GLOBAL PINGUECULUM DRUGS MARKET: BY REGION (2021) 133
  • FIGURE 46 GLOBAL PINGUECULUM DRUGS MARKET: BY REGION (2022 & 2029) 133
  • FIGURE 47 GLOBAL PINGUECULUM DRUGS MARKET: BY REGION (2021 & 2029) 134
  • FIGURE 48 GLOBAL PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 134
  • FIGURE 49 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 137
  • FIGURE 50 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021) 139
  • FIGURE 51 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029) 139
  • FIGURE 52 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029) 140
  • FIGURE 53 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 140
  • FIGURE 54 EUROPE PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 192
  • FIGURE 55 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2021) 194
  • FIGURE 56 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029) 194
  • FIGURE 57 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029) 195
  • FIGURE 58 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 195
  • FIGURE 59 NORTH AMERICA PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 262
  • FIGURE 60 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021) 264
  • FIGURE 61 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029) 264
  • FIGURE 62 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029) 265
  • FIGURE 63 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 265
  • FIGURE 64 SOUTH AMERICA PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 283
  • FIGURE 65 SOUTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021) 285
  • FIGURE 66 SOUTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029) 285
  • FIGURE 67 SOUTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029) 286
  • FIGURE 68 SOUTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 286
  • FIGURE 69 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 305
  • FIGURE 70 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021) 307
  • FIGURE 71 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029) 307
  • FIGURE 72 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029) 308
  • FIGURE 73 MIDDLE EAST AND AFRICA PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 308
  • FIGURE 74 GLOBAL PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%) 338
  • FIGURE 75 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%) 339
  • FIGURE 76 NORTH AMERICA PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%) 340
  • FIGURE 77 EUROPE PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%) 341
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!